Abstract
Erythroid differentiation program is comprised of lineage commitment, erythroid progenitor proliferation, and termination differentiation. Each stage of the differentiation program is heavily influenced by epigenetic modifiers that alter the epigenome in a dynamic fashion influenced by cytokines/humeral factors and are amicable to target by drugs. The epigenetic modifiers can be classified as DNA modifiers (DNMT, TET), mRNA modifiers (RNA methylases and demethylases) and histone protein modifiers (methyltransferases, acetyltransferases, demethylases, and deacetylases). Here we describe mechanisms by which these epigenetic modifiers influence and guide erythroid-lineage differentiation during normal and malignant erythropoiesis and also benign diseases that arise from their altered structure or function.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 15-26 |
| Number of pages | 12 |
| Journal | Seminars in hematology |
| Volume | 58 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2021 |
ASJC Scopus subject areas
- Hematology
Fingerprint
Dive into the research topics of 'Epigenetic modifiers in normal and aberrent erythropoeisis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS